Heather Turner is Chief Executive Officer of LB Pharmaceuticals Inc (LBRX). The company reported total compensation of $11,884,985 for fiscal year 2025.
| Salary | $568,750 |
|---|---|
| Bonus | $321,406 |
| Stock awards | $0 |
| Option awards | $10,865,221 |
| Non-equity incentive plan | $0 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $129,608 |
| Total | $11,884,985 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure LB Pharmaceuticals Inc filed April 23, 2026, accession 0001193125-26-173679.
| Fiscal year | Role | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|---|
| FY2025 | Chief Executive Officer | $568,750 | $321,406 | $0 | $10,865,221 | $0 | $0 | $129,608 | $11,884,985 |
| FY2024 | Chief Executive Officer | $68,750 | $0 | $0 | $4,709,607 | $0 | $0 | $14,333 | $4,792,690 |
Totals as disclosed in each year's own compensation disclosure for LB Pharmaceuticals Inc.
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Heather Turner this page | Chief Executive Officer | $11,884,985 |
| Gad Soffer | Chief Operating and Business Officer | $3,808,637 |
| Anna Eramo | Chief Medical Officer | $2,376,939 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full LB Pharmaceuticals Inc compensation brief.
Heather Turner's compensation sits inside LB Pharmaceuticals Inc's full executive and board picture — the peer group, pay against peers, incentive design and the board itself.